Bayrab market seen expanding as rabies cases and bite incidents rise

Nov. 2, 2026
Bayrab market seen expanding as rabies cases and bite incidents rise
By AI, Created 15:00 UTC, Nov 02, 2026, AGP -

The Business Research Company says the global Bayrab vaccine market is set for steady growth through 2026 and beyond, driven by rising rabies cases, more dog bites, and higher healthcare spending. North America held the largest market share in 2025, while the report points to broader growth in vaccination programs and vaccine manufacturing.

Why it matters: - Bayrab is used to help prevent rabies, a fatal viral disease, after exposure or before exposure in high-risk groups. - Rising rabies cases and more dog bite incidents increase demand for post-exposure protection. - Higher healthcare spending can improve access to rabies vaccines and emergency treatment.

What happened: - The Business Research Company released its Bayrab Market Global Market Report 2026 – Market Size, Trends, And Forecast 2026-2035. - The report says the Bayrab vaccine market is gaining attention as global health efforts intensify to combat rabies. - The market is expected to grow from 2024 to 2026, with further expansion projected beyond that period. - North America held the largest share of the Bayrab market in 2025.

The details: - The report links market growth to expanded vaccine production, stronger immunization programs, and better distribution infrastructure. - Other growth drivers include rising stray animal populations, global vaccination efforts, technological advances in vaccine manufacturing, and government support for zoonotic disease control. - The report highlights wider adoption of pre-exposure and post-exposure prophylaxis, development of cell-based vaccines, and international anti-rabies campaigns as emerging trends. - Bayrab works by triggering the immune system to produce protective antibodies against rabies. - The vaccine is used for both pre-exposure prophylaxis in high-risk groups and post-exposure treatment after possible rabies contact. - The vaccine is available in chick embryo cell, vero cell, human diploid cell vaccine (HDCV), and baby hamster kidney (BHK) cell formats. - Rising rabies incidence is a major market driver, especially where stray dog populations are growing and post-exposure prophylaxis is harder to access. - South Dakota reported a 122% increase in rabies cases in 2023, with 20 animals testing positive versus 9 in 2022. - U.S. national health spending rose 7.5% to $4.9 trillion in 2023 from $4.5 trillion in 2022. - Tower Hamlets London Borough Council reported dog bite incidents requiring medical care rose from 0.55% in 2022 to 1.2% in 2024. - The report covers Asia-Pacific, Western Europe, Eastern Europe, South America, the Middle East, and Africa.

Between the lines: - The market outlook suggests rabies prevention is moving from a reactive public health need to a broader, sustained vaccination and preparedness market. - North America's current lead may reflect stronger healthcare access and reporting, but growth opportunities appear spread across regions where vaccination gaps remain. - The report's focus on cell-based vaccines and forecasting tools points to a market that is becoming more technologically developed and data driven.

What's next: - Continued vaccination programs, vaccine manufacturing upgrades, and distribution improvements are likely to support market growth. - Ongoing efforts to control stray animals and expand access to post-exposure prophylaxis could shape demand by region. - The report says future market dynamics may shift as healthcare systems and vaccination efforts improve outside North America. - More information is available in the sample report and the full report.

Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.

Sign up for:

Asia Pacific News Today

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Asia Pacific News Today

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.